WHR
61
3
DVA
62
5
SJM
17
5
CMA
42
3
STT
48
4
FOX
71
3
USB
50
3
VRSK
54
2
T
32
2
SRE
37
9
AA
27
5
MDLZ
28
2
FCX
44
4
XEL
48
11
MMM
35
3
CCL
68
6
MET
58
2
STZ
42
2
MA
60
5
PSA
43
6
WHR
61
3
DVA
62
5
SJM
17
5
CMA
42
3
STT
48
4
FOX
71
3
USB
50
3
VRSK
54
2
T
32
2
SRE
37
9
AA
27
5
MDLZ
28
2
FCX
44
4
XEL
48
11
MMM
35
3
CCL
68
6
MET
58
2
STZ
42
2
MA
60
5
PSA
43
6
Financhill
Back

TG Therapeutics 10K Form

Buy
60

TGTX
TG Therapeutics

Last Price:
$32.22
Seasonality Move:
63.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TGTX News And Ratings

See the #1 stock for the next 7 days that we like better than TGTX

TGTX Financial Statistics

Sales & Book Value

Annual Sales: $233.7M
Cash Flow: $-12.2M
Price / Cash Flow: 56.26
Annual Sales: $1.23
Price / Book: 26.1

Profitability

EPS (TTM): -0.11000
Net Income (TTM): $-14.4M
Gross Margin: $219.5M
Return on Equity: -8.4%
Return on Assets: -3.55%

TG Therapeutics Earnings Forecast

Key TG Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 28 years for TGTX is 93.95%.
  • The Selling, General & Administrative Expenses for TGTX have been equal to 52.51% of Gross Profit Margin.
  • The Research & Development expenses have been 32.61% of Revenue.
  • The Interest Expense is 99.55% of Operating Income.
  • The Net Earning history of TGTX is 5.42% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 14 years.

TG Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TGTX
CUSIP: 88322Q
Website: tgtherapeutics.com

Debt

Debt-to-Equity Ratio: 1.27
Current Ratio: 4.59
Quick Ratio: 3.65

Price-to-Earnings

Trailing P/E Ratio: 358
Forward P/E Ratio: 34.94

TGTX Technical Analysis vs Fundamental Analysis

Buy
60
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics a Buy or a Sell?

  • TG Therapeutics stock is rated a Buy
    The current TG Therapeutics [TGTX] share price is $32.22. The Score for TGTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.